Literature DB >> 15105134

Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.

John E Bennett1, Koichi Izumikawa, Kieren A Marr.   

Abstract

Candida glabrata can become resistant to fluconazole, causing persistent colonization and invasive infection during prolonged exposure to the drug. To determine the mechanism of resistance in this setting, weekly oropharyngeal cultures for C. glabrata were obtained over a 2-year period from hematopoietic stem cell transplant recipients who were receiving fluconazole prophylaxis. In 20 patients from whom at least two isolates of the same karyotype were obtained more than two weeks apart, fluconazole MICs doubled every 31 days on average. The mechanism of fluconazole resistance in isolates from the 14 of the 20 patients studied in whom MICs changed at least fourfold was studied. Cellular resistance was accompanied by increased drug efflux as measured by decreased accumulation of fluconazole and rhodamine 6G and increased abundance of transcripts from two drug transporters, CgCDR1 and PDH1. The rapidity and regularity of the rising resistance indicated that C. glabrata is able to upregulate drug efflux without losing the ability to maintain colonization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105134      PMCID: PMC400565          DOI: 10.1128/AAC.48.5.1773-1777.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections.

Authors:  M N Khattak; J P Burnie; R C Matthews; B A Oppenheim
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 3.  Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.

Authors:  Dominique Sanglard; Frank C Odds
Journal:  Lancet Infect Dis       Date:  2002-02       Impact factor: 25.071

4.  The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.

Authors:  D Sanglard; F Ischer; D Calabrese; P A Majcherczyk; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates.

Authors:  F Barchiesi; L Falconi Di Francesco; D Arzeni; F Caselli; D Gallo; G Scalise
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

6.  Electrophoretic karyotypes of Torulopsis glabrata.

Authors:  C S Kaufmann; W G Merz
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

7.  In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

Authors:  M A Pfaller; S A Messer; R J Hollis; R N Jones; D J Diekema
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans.

Authors:  K A Marr; C N Lyons; K Ha; T R Rustad; T C White
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata.

Authors:  K Asakura; S Iwaguchi; M Homma; T Sukai; K Higashide; K Tanaka
Journal:  J Gen Microbiol       Date:  1991-11

10.  Function of Candida glabrata ABC transporter gene, PDH1.

Authors:  Koichi Izumikawa; Hiroshi Kakeya; Huei-Fung Tsai; Brian Grimberg; John E Bennett
Journal:  Yeast       Date:  2003-02       Impact factor: 3.239

View more
  84 in total

Review 1.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.

Authors:  Annemarie Borst; Maria T Raimer; David W Warnock; Christine J Morrison; Beth A Arthington-Skaggs
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.

Authors:  Jon A Olson; Jill P Adler-Moore; P J Smith; Richard T Proffitt
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital.

Authors:  Krishnapriya Kalaiarasan; Rakesh Singh; Latha Chaturvedula
Journal:  J Clin Diagn Res       Date:  2017-03-01

5.  Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.

Authors:  Sarah G Whaley; Qing Zhang; Kelly E Caudle; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.

Authors:  Sheng-Yuan Ruan; Chen-Chen Chu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

7.  STB5 is a negative regulator of azole resistance in Candida glabrata.

Authors:  Jason A Noble; Huei-Fung Tsai; Sara D Suffis; Qin Su; Timothy G Myers; John E Bennett
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

8.  Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.

Authors:  John-Paul Vermitsky; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.

Authors:  Edward Sionov; Hyeseung Lee; Yun C Chang; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

10.  Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.

Authors:  Sélène Ferrari; Françoise Ischer; David Calabrese; Brunella Posteraro; Maurizio Sanguinetti; Giovanni Fadda; Bettina Rohde; Christopher Bauser; Oliver Bader; Dominique Sanglard
Journal:  PLoS Pathog       Date:  2009-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.